Diabetes
Researchers from Sweden, the United Kingdom and Russia provide details of new studies and findings in the area of diabetes
Published in Obesity and Diabetes Week, October 16th, 2006
Study 1: Pioglitazone achieves glycemic targets, reduces risk factors involved in atherosclerosis and improves beta-cell function in patients with type 2 diabetes.
In a recent report published in the Journal of Internal Medicine, researchers in Sweden conducted a study "to examine pioglitazone as add-on to metformin and insulin secretagogues in patients with type 2 diabetes and inadequate glycaemic control and its effect on glycaemic control, surrogate measures of insulin sensitivity (adiponectin) and beta-cell function (proinsulin/insulin) and fluid...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week
More Articles from Obesity and Diabetes Week
- Diabetes & Obesity
Effect of fatty acids on endothelium-dependent relaxation in rabbit aorta discussed - Endocrinology
In 3T3-L1 adipocytes, Sp1 mediates repression of resistin gene by PPAR gamma agonists - Fitness & Wellness
Visceral and subcutaneous fat changes in diabetes correlated negatively with physical activity - Insulin Resistance
Mahoganoid mutation may raise insulin sensitivity via hypothalamic melanocortin-3 receptor path - Obesity Research
Diverticulitis, common in older adults, is now seen in young, obese adults - Angiology
Brachial artery flow-mediated dilation does not reflect basal release of NO in type 2 diabetes - More from this issue of Obesity and Diabetes Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
